Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 9/20 | 0.61 |
| ▸ | ALK | Q9UM73 | 10/20 | 0.56 |
| ▸ | INSR | P06213 | 6/20 | 0.56 |
| ▸ | IGF1R | P08069 | 5/20 | 0.56 |
| ▸ | ZAP70 | P43403 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.54 |
| ▸ | AURKA | O14965 | 1/20 | 0.53 |
| ▸ | ROS1 | P08922 | 1/20 | 0.53 |
| ▸ | EML4 | Q9HC35 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24326983 | 0.93 | EGFR (0.63) | EGFRALKINSRIGF1RZAP70 | |
| SCHEMBL24327482 | 0.92 | EGFR (0.62) | EGFRALKINSRIGF1RZAP70 | |
| SCHEMBL24328348 | 0.87 | EGFR (0.65) | EGFRALKINSRIGF1RZAP70 | |
| SCHEMBL24326982 | 0.87 | ALK (0.74) | EGFRALKINSRIGF1RZAP70 | |
| SCHEMBL24328341 | 0.86 | EGFR (0.67) | EGFRALKINSRIGF1RZAP70 | |
| SCHEMBL24327472 | 0.85 | EGFR (0.64) | EGFRALKINSRIGF1RZAP70 | |
| SCHEMBL24327331 | 0.84 | EGFR (0.62) | EGFRALKINSRIGF1RZAP70 | |
| SCHEMBL24327355 | 0.84 | EGFR (0.62) | EGFRALKINSRIGF1RZAP70 | |
| SCHEMBL24327578 | 0.84 | EGFR (0.62) | EGFRALKINSRIGF1RZAP70 | |
| SCHEMBL24327466 | 0.83 | EGFR (0.65) | EGFRALKINSRIGF1RZAP70 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022063106-A1 | INDOLINE COMPOUNDS AND DERIVATIVES AS EGFR INHIBITORS | BEIGENE, LTD. (KY) | 2022-03-31 | — | — | WO | disclosed |